York University’s Global Strategy Lab has received $9.6M from global health philanthropy organization Wellcome to support its AMR Policy Accelerator. The accelerator catalyzes scientific research and evidence-based policy to support governments as they act on the ongoing crisis of antimicrobial resistance. “Antimicrobial resistance is one of the most urgent health threats of our time, and meeting it will take strong evidence, global collaboration and a real commitment to equity,” said YorkU Interim President Lisa Phillips. “The Global Strategy Lab brings all three. York is proud to be the home of this work, and grateful to Wellcome for backing it over the long term.”